CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Duopharma Biotech Bhd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Duopharma Biotech Bhd
Lot 2599, Jalan Seruling 59, Kawasan 3,
Phone: +60 333232759p:+60 333232759 KLANG, 41200  Malaysia Ticker: DPHARMADPHARMA
Business Summary
Duopharma Biotech Berhad is a pharmaceutical company. The Company is engaged in the manufacture and distribution of pharmaceutical products. Its Consumer Healthcare (CHC) business is responsible for the marketing and distribution of over-the-counter products, including vitamins, minerals and supplements and cosmeceuticals in the domestic and regional markets. Its Ethical Classic Business is involved in the manufacture, distribution and sales of drugs that treat a wide range of ailments, from cardiovascular, dermatological and hormonal conditions to respiratory, sensory, nervous and musculoskeletal system diseases, among others. Its Ethical Specialty Business focuses on treatments, including generics and biosimilars-that target its three specialty (or franchise) areas, namely kidney disease, cancer and diabetes. It has core competencies in the pharmaceutical industry inclusive of manufacturing, research and development and commercialization and marketing of over 300 generic drugs.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board KartiniBinti Hj Abdul Manaf 62 6/7/2024 6/1/2023
Chief Financial Officer Wu KongChek 58 7/1/2012 8/1/2000
Chief Executive Officer Duopharma Consumer Healthcare Sdn Bhd Shamsul IdhamBin A.iahad 51 1/1/2020 1/1/2020
11 additional Officers and Directors records available in full report.

Business Names
Business Name
CCM Duopharma Biotech Berhad
CCMDBIO
DPHARMA
Duopharma Biotech Berhad

General Information
Number of Employees: 1,940 (As of 12/31/2023)
Outstanding Shares: 961,942,000 (As of 9/30/2024)
Shareholders: 20,526
Stock Exchange: KUL
Fax Number: +60 333233923


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 21, 2024